HIM
SNY icon

Hillsdale Investment Management’s Sanofi SNY Stock Holding History

Hillsdale Investment Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-180
Closed -$9K – 667
2020
Q4 		$9K Hold
180
– – ﹤0.01% 509
2020
Q3 		$9K Buy
180
+60
+50% +$3.09K ﹤0.01% 502
2020
Q2 		$6K Hold
120
– – ﹤0.01% 496
2020
Q1 		$5K Buy
+120
New +$5.74K ﹤0.01% 526

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Hillsdale Investment Management's SNY Position: Q1 2021 in Review

Hillsdale Investment Management sold out of Sanofi (SNY) in Q1 2021, closing a stake of 180 shares — an estimated $9K sold.

Hillsdale Investment Management first reported a position in SNY in Q1 2020 and held it in 4 quarters. The position peaked at $9K in Q4 2020. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Hillsdale Investment Management reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Hillsdale Investment Management sold 180 Sanofi shares in Q1 2021, an estimated $9K.
  • Hillsdale Investment Management first reported a position in Sanofi in Q1 2020 and held it in 4 quarters.
  • Hillsdale Investment Management's Sanofi position peaked at $9K in Q4 2020.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Hillsdale Investment Management's 13F filing for Q1 2021, filed 22 Apr 2021.